The National Cataract Audit is currently funded through participation fees from centres as well as financial contributions from Alcon, Bausch + Lomb and Rayner.
The Age-Related Macular Degeneration (AMD) Audit is currently part-funded by Roche Products Limited and Bayer plc who have funded the AMD Audit since its commencement.
Roche Products Limited have provided a grant to support the development of the audit tool as a non-interventional study. Other than certification of the protocol, Roche Products Limited have had no involvement in the development of the tool or any audit outputs. The project has been supported by an unrestricted, hands-off grant provided by Bayer plc. Bayer plc has no involvement whatsoever in the development or implementation of the project. We are grateful for the donations received from these organisations. We also receive ongoing support through subscription fees from participating hospitals.
